Cancer Treatment Centers of America in Tulsa Announce Staff Addition, Promotion
Posted on: Monday, 29 August 2005, 21:01 CDT
Medical oncologist/hematologist Sagun Shrestha, MD has joined Cancer Treatment Centers of America at Southwestern Regional Medical Center in Tulsa. In addition, pulmonologist Daniel Nader, DO has been elected to vice chief of staff by the hospital's medical staff.
Dr. Shrestha recently completed advanced training in hematology and oncology and served as chief fellow at Albert Einstein College of Medicine in New York.
Dr. Nader joined CTCA in 1990 as cardiopulmonary medical director. He currently serves as the medical director of the Lung Cancer Center. In addition, Dr. Nader is a professor at the Oklahoma State University Center for Health Sciences.
Cancer Treatment Centers of America is Oklahoma's only major hospital totally focused on cancer. The hospital embraces an integrative approach to cancer care, combining traditional treatment options with complementary therapies under one roof.
Source: Journal Record - Oklahoma City
Related Articles
- Philips' SmartArc Solution Helps Moffitt Cancer Center Reduce Radiation Treatment Time
- American Airlines Applauded for Its Fundraising to Support Susan G. Komen for the Cure(R), Promise Grant to The University of Texas M. D. Anderson Cancer Center
- Providence Holy Cross Cancer Center Offers Advanced Image-Guided Radiotherapy Treatments Using New Technology From Varian Medical Systems
- National Association of Cancer Center Development Officers Selects Grizzard As Agency of Record
- MD Anderson Cancer Center Joins Protox Cancer Study
- Florida Cancer Centers First to Implement Sicel's DVS(R) Implantable Radiation Sensor in the Treatment of Breast and Prostate Cancer
- Top Malaysian Cancer Center Begins Treatments Using World's Most Versatile and Advanced Radiotherapy Machine
- Two Leading Swedish Cancer Centers Expand Radiotherapy Facilities With Equipment From Varian Medical Systems
- InterCommunity Cancer Center in Leesburg Introduces IsoRay Medical, Inc.'s Cesium-131 Medical Isotope for Treating Prostate Cancer; First Implant in Florida Using Breakthrough Treatment Scheduled for Today (Wednesday, April 26)
- Medical Center Hospital to Build New Cancer Center
 |
 |
User Comments (0)
RSS Feeds